How do you pay?

How to pay the least

Ask for the cash price

Generic ethinyl estradiol and norethindrone

No pharmacy we check posts a price for it.

  1. Ask your pharmacy for the cash price of generic ethinyl estradiol and norethindrone.Find pharmacies near you 
  2. Ask one or two other pharmacies too. Cash prices for the same generic can differ a lot from store to store.

A regular generic has the same active ingredient as Tri-Norinyl, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameTri-Norinyl
Authorized genericethinyl estradiol and norethindrone
Regular genericethinyl estradiol and norethindrone
What you’d pay
Not soldNo longer sold
Not soldNo longer sold
Cash priceAsk the pharmacy
Same as Tri-Norinyl?
–
–
Same active ingredientFillers and dyes can differ

Brand nameNot sold

Tri-Norinyl itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.

See the regular generic →

Authorized genericNot sold now

An authorized generic of Tri-Norinyl was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (ethinyl estradiol and norethindrone) is available.

Source: FDA, updated October 30, 2026

Regular genericWho makes it

One company sells a generic of Tri-Norinyl that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Teva Pharmaceuticals

    Has lactose · Has dyes: D&C Yellow No. 10 aluminum lake, FD&C Yellow No. 6 · Sold as Aranelle · Made by Barr

    How it looks, what’s in it, NDCs

    PackageNDC
    Carton of 30555-9066-67

    Inactive ingredients: D&C Yellow No. 10 aluminum lake, lactose monohydrate, magnesium stearate, starch, corn, anhydrous lactose, FD&C Yellow No. 6, microcrystalline cellulose

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptive products such as Norinyl, which contain 50 mcg of estrogen, should not be used unless medically indicated. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. 1 The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. ___________________________________________________________________________________________ Table I: Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year. United States % of Women Experiencing an Unintended Pregnancy within the First Year of Use Method

Chance4 Spermicides5

Periodic abstinence Calendar Ovulation method Sympto-thermal6 Post-ovulation Withdrawal Cap7 Parous women Nulliparous women Sponge Parous women

Typical use1

Perfect use2

% of Women Continuing Use at One Year3

Diaphragm7 Condom8 Pill

Nulliparous women

Female (Reality) Male

Progestin only Combined

IUD

Progesterone T Copper T 380A

LNg 20

Depo-Provera Norplant and Norplant-2

Female sterilization Male sterilization

Emergency Contraceptive Pills: Treatment initiated within 72 hours after unprotected intercourse reduces the risk

of pregnancy by at least 75%. 9 Lactational Amenorrhea Method: LAM is a highly effective, temporary method of contraception. 10 Source: Trussell J. Contraceptive Efficacy Table from Hatcher R.A., Trussell J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, in Contraceptive Technology: Seventeenth Revised Edition. New York, NY: Irvington Publishers, 1998. 1 Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. 2 Among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. 3 Among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year. 4 The percents becoming pregnant in columns and are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. Among such populations, about 89% become pregnant within one year. This estimate was lowered slightly (to 85%) to represent the percent who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether. 5 Foams, creams, gels, vaginal suppositories, and vaginal film. 6 Cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases. 7 With spermicidal cream or jelly. 8 Without spermicides. 9 The treatment schedule is one dose within 72 hours after unprotected intercourse and a second dose 12 hours after the first dose. The Food and Drug Administration has declared the following brands of oral contraceptives to be safe and effective for emergency contraception: Ovral (1 dose is 2 white pills), Aleese (1 dose is 5 pink pills), Nordette or Levlen (1 dose is 2 light-orange pills), Lo/Ovral (1 dose is 4 white pills), Triphasil or Tri-Levlen (1 dose is 4 yellow pills). 10 However, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches six months of age.

Source: the FDA label for Tri-Norinyl (Dr Reddys Labs Sa), April 29, 2022. Full label from the FDA (PDF)